| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.700 | strong | 0.962 | 1 | 1 | 1996 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.700 | None | 0.993 | 1 | 1 | 1995 | 2020 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.700 | None | 0.978 | 1 | 1 | 1983 | 2020 | ||||||||
|
interferon regulatory factor 6 | 0.486 | 0.769 | 1.00 |
|
disease | 0.700 | strong | 0.952 | 1 | 1 | 1999 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.700 | None | 0.984 | 1 | 1 | 1980 | 2020 | ||||||||
|
leptin receptor | 0.433 | 0.808 | 0.99 |
|
disease | 0.700 | None | 0.930 | 1 | 1 | 1966 | 2019 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.700 | None | 0.941 | 1 | 1 | 1998 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.700 | None | 1.000 | 1 | 1 | 1992 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.700 | None | 1.000 | 1 | 1 | 1996 | 2016 | ||||||||
|
myocilin | 0.595 | 0.500 | 7.6E-12 |
|
disease | 0.700 | None | 0.979 | 1 | 1 | 1995 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.700 | None | 0.942 | 1 | 1 | 1996 | 2019 | ||||||||
|
endoplasmic reticulum aminopeptidase 1 | 0.556 | 0.692 | 2.1E-26 |
|
disease | 0.700 | None | 1.000 | 1 | 1 | 2013 | 2020 | ||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.700 | None | 1.000 | 1 | 1 | 2005 | 2019 | ||||||||
|
reelin | 0.515 | 0.731 | 1.00 |
|
disease | 0.700 | None | 0.909 | 1 | 1 | 1998 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.700 | None | 0.975 | 1 | 1 | 1992 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.939 | 1 | 1 | 2002 | 2020 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.700 | None | 0.909 | 1 | 3 | 1998 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.700 | None | 0.968 | 1 | 1 | 2005 | 2020 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
disease | 0.700 | None | 0.900 | 1 | 1 | 1995 | 2018 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.700 | None | 1.000 | 1 | 1 | 2002 | 2020 | ||||||||
|
caspase recruitment domain family member 14 | 0.546 | 0.846 | 1.2E-19 |
|
disease | 0.700 | strong | 0.947 | 1 | 1 | 2003 | 2019 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.700 | None | 0.980 | 1 | 1 | 2004 | 2019 | ||||||||
|
SH3 and multiple ankyrin repeat domains 3 | 0.550 | 0.731 | 1.00 |
|
disease | 0.700 | None | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
neurexin 1 | 0.581 | 0.692 | 1.00 |
|
disease | 0.700 | None | 0.932 | 1 | 1 | 2008 | 2019 | ||||||||
|
notch receptor 2 | 0.441 | 0.808 | 1.00 |
|
disease | 0.680 | None | 1.000 | 1 | 1 | 2004 | 2019 |